Alliance Pharma (APH.L) Stock Price

£61.4 0.3%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    4
  • Fundamental

    6
  • Technical

    9

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Alliance Pharma, AI stock picks, stock alerts and much more.

Sign up

APH.L AI Stock Analysis

AI stock analysis for APH.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Alliance Pharma (APH.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Alliance Pharma (APH.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Alliance Pharma (APH.L), currently trading at £61.4, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About APH.L

LSE
  • Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.

  • Symbol

    APH.L

  • Market

    LSE

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Market Cap

    331.9M

Similar Stocks

0A4X.L DMK Pharmaceuticals
0A4X.L
$0.0009
0.00%
6
STX.L Shield Therapeutics
STX.L
£3.07
9.2%
4
INDV.L Indivior PLC
INDV.L
£842.5
3.8%
5
HLN.L Haleon plc
HLN.L
£379
0.2%
6
HCM.L HUTCHMED (China) Limited
HCM.L
£225.1
1.6%
5

APH.L Alternative Data

Web Traffic

Alliance Pharma receives an estimated 6519 monthly visitors to alliancepharmaceuticals.com.

  • Web Traffic

    6519

  • Change from Previous Month

    23.8%

  • 3 Month Change

    37.9%

News Mentions

Alliance Pharma was mentioned 3 times in the news yesterday.

  • News Mentions

    3

  • Daily Change

    25%

  • 1 Month Change

    0%

  • 3 Month Change

    200%

LinkedIn Followers

17,235 are following Alliance Pharma on LinkedIn, up by 3% over the last month.

  • LinkedIn Followers

    17235

  • Daily Change

    0%

  • 1 Month Change

    3%

  • 3 Month Change

    5.1%

Job Postings

Alliance Pharma currenly has an estimated 3 open job postings.

  • Job Postings

    3

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Alliance Pharma has 510 employees, up by 0.4% over the last month.

  • LinkedIn Employees

    510

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    0.2%

Business Outlook
  • Business Outlook

    62

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

APH.L Financials

APH.L Key Metrics
  • Total Revenue

    £83.9M

  • Net Income

    £4.7M

  • Earnings per Share

    £0.0086

  • Free cash flow

    £8.8M

  • EBITDA

    £15.7M

  • EBITDA Ratio

    0.187396

  • Total Assets

    £398.3M

APH.L 2-year Revenue & Income
APH.L 2-year Free Cash Flow

APH.L Technicals

APH.L SMA
APH.L RSI

FAQ

What's the current price of Alliance Pharma (APH.L) Stock?
The price of an Alliance Pharma (APH.L) share is £61.4.

What's the market cap of Alliance Pharma?
The current market cap of Alliance Pharma is 331.9M.

Should I buy or sell APH.L?
Alliance Pharma shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Alliance Pharma is better viewed as a hold or accumulate position while waiting for further developments.

Is Alliance Pharma a good investment?
The current analysis of Alliance Pharma's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Alliance Pharma's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Alliance Pharma (APH.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Alliance Pharma stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Alliance Pharma (APH.L) that investors often compare it to?
Alliance Pharma (APH.L) is often compared to similar stocks such as DMK Pharmaceuticals, Shield Therapeutics, Indivior PLC, Haleon plc and HUTCHMED (China) Limited.

What is the forecast for Alliance Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Alliance Pharma's stock price to be around £62.22 in 2026. Starting from the current price of £61.4, this represents a 1.3% change in price, indicating a neutral outlook for the stock.

How to buy Alliance Pharma (APH.L) Stock?
Alliance Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Alliance Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.